CVRx (CVRX) Cash from Financing Activities (2020 - 2026)
CVRx (CVRX) recorded quarterly Cash from Financing Activities of $8.9 million in Q1 2026, up 2066.34% quarter-over-quarter from $410000.0 in Q4 2025, and down 7.62% on a YoY basis from $9.6 million in Q1 2025.
CVRx (CVRX) Cash from Financing Activities (2020 - 2026) Analysis & Trends
CVRx's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 7.62% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $9.8 million (down 84.74% YoY), while the FY2025 annual figure was $10.5 million, down 81.17% from the prior year.
- Cash from Financing Activities was $8.9 million for Q1 2026 at CVRx, up from $410000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $40.2 million in Q3 2024 to a low of $7000.0 in Q3 2022.
- Historically, Cash from Financing Activities has averaged $6.3 million across 5 years, with a median of $473000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities tumbled 99.99% in 2022, then surged 15666.67% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at $7.1 million in 2022, then soared by 118.91% to $15.6 million in 2023, then retreated by 11.21% to $13.8 million in 2024, then slumped by 97.04% to $410000.0 in 2025, then surged by 2066.34% to $8.9 million in 2026.
- The last three Cash from Financing Activities figures came in at $8.9 million (Q1 2026), $410000.0 (Q4 2025), and $103000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | CVRx | 132.04 Mn | 59.74 Mn | 12.88 Mn | 8.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.88 Mn |
| Mar 31, 2026 | 8.88 Mn |
| Dec 31, 2025 | 410,000.00 |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Mar 31, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Jun 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 15.58 Mn |
| Dec 31, 2023 | 15.58 Mn |